KUSURI NO AOKI HOLDINGS CO.,LTD. AI Stock Analysis
Want to see JP:3549 full AI Analyst Report?
KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) AI Stock Analysis
KUSURI NO AOKI HOLDINGS CO.,LTD.
(TSE/TYO:3549)
The score is held back primarily by financial performance: a sharp 2026 revenue decline, higher leverage, and volatile free cash flow outweigh the otherwise steady profitability and positive operating cash flow. Technicals are moderately supportive with the stock above key moving averages, but negative MACD and a higher RSI temper the trend. Valuation is middling (P/E ~22) with a low dividend yield, providing limited cushion.
KUSURI NO AOKI HOLDINGS CO.,LTD. (3549) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 481.75B
- Dividend Yield
- 0.29%
- Average Volume (3M)
- 300.76K
- Price to Earnings (P/E)
- 26.3
- Beta (1Y)
- 0.33
- Revenue Growth
- 12.54%
- EPS Growth
- 15.87%
- Country
- Japan
- Employees
- 6,355
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
KUSURI NO AOKI HOLDINGS CO.,LTD. Business Overview & Revenue Model
Company Description
Founded in 1999 and headquartered in Hakusan, Japan, Kusuri No Aoki Holdings Co., Ltd. primarily engages in the sale and dispensing of medications, cosmetics, and various everyday consumer products across Japan.
How the Company Makes Money
The company makes money primarily through retail sales generated at its drugstore locations. Revenue is earned from the sale of (1) prescription-related products and services (e.g., dispensing associated with pharmacies) and (2) front-of-store mercha...
KUSURI NO AOKI HOLDINGS CO.,LTD. Financial Statement Overview
Summary
Income statement is solid but cooling: strong multi-year revenue growth was followed by a notable 2026 revenue decline (-11.6%) and slightly lower net income vs 2025. Balance sheet risk increased as debt rose materially in 2026, reducing flexibility. Operating cash flow is positive and improved in 2026, but free cash flow has been volatile and relatively modest recently, weakening overall cash quality.
Income Statement
62PositiveBalance Sheet
56NeutralCash Flow
48Neutral| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 586.17B | 566.87B | 501.47B | 436.88B | 378.87B | 328.33B |
| Gross Profit | 139.66B | 135.03B | 120.47B | 106.29B | 94.64B | 80.98B |
| EBITDA | 45.60B | 42.87B | 39.18B | 32.00B | 28.74B | 23.76B |
| Net Income | 18.97B | 17.13B | 17.79B | 12.31B | 12.33B | 9.84B |
Balance Sheet | ||||||
| Total Assets | 406.45B | 410.94B | 352.46B | 303.45B | 276.33B | 236.08B |
| Cash, Cash Equivalents and Short-Term Investments | 58.99B | 58.93B | 47.73B | 49.13B | 42.87B | 26.35B |
| Total Debt | 143.57B | 149.77B | 99.32B | 98.78B | 89.50B | 78.13B |
| Total Liabilities | 261.41B | 269.90B | 206.70B | 186.03B | 177.78B | 149.14B |
| Stockholders Equity | 145.04B | 141.04B | 145.76B | 117.42B | 98.55B | 86.93B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.84B | 448.00M | 7.20B | 10.84B | -6.26B |
| Operating Cash Flow | 0 | 37.32B | 22.17B | 26.86B | 31.25B | 20.29B |
| Investing Cash Flow | 0 | -42.88B | -31.08B | -21.10B | -22.26B | -27.77B |
| Financing Cash Flow | 0 | 16.49B | 7.67B | 344.00M | 7.53B | 18.10B |
KUSURI NO AOKI HOLDINGS CO.,LTD. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3549, the sentiment is Positive. The current price of 5073.00 is above the 20-day moving average (MA) of 4583.95, above the 50-day MA of 4271.04, and above the 200-day MA of 3947.45, indicating a bullish trend. The MACD of 245.59 indicates Negative momentum. The RSI at 68.02 is Neutral, neither overbought nor oversold. The STOCH value of 92.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3549.
KUSURI NO AOKI HOLDINGS CO.,LTD. Peers Comparison
Overall Rating
JP:339181Outperform
JP:314870Outperform
JP:764969Neutral
JP:998969Neutral
JP:334959.9Neutral
JP:354956Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | JPY 1.13T | 20.31 | 7.13% | 1.88% | ― | ― | |
| 70Outperform | JPY 207.99B | 12.89 | ― | 2.83% | 8.67% | 3.24% | |
| 69Neutral | JPY 550.50B | 17.88 | 9.94% | 1.24% | 8.97% | -29.54% | |
| 69Neutral | JPY 458.81B | 15.65 | 11.04% | 3.36% | 3.99% | -0.48% | |
| 60Neutral | JPY 512.38B | 16.29 | ― | 1.27% | 8.99% | 3.61% | |
| 56Neutral | JPY 485.06B | 26.29 | ― | 0.29% | 12.54% | 15.87% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3549 | KUSURI NO AOKI HOLDINGS CO.,LTD. | 5073.00 | 1236.35 | 32.22% | |
| JP:9989 | Sundrug Co | 3924.00 | -187.45 | -4.56% | |
| JP:7649 | Sugi Holdings Co | 1416.50 | -292.70 | -17.12% | |
| JP:3391 | TSURUHA Holdings | 2500.00 | -202.22 | -7.48% | |
| JP:3148 | Create SD Holdings Co., Ltd. | 3290.00 | 167.31 | 5.36% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6437.00 | -929.03 | -12.61% |
KUSURI NO AOKI HOLDINGS CO.,LTD. Corporate Events
Kusuri No Aoki Reports Treasury-Share Purchases
KUSURI NO AOKI HOLDINGS CO., LTD. announced that it purchased 51,400 common shares for ¥223,680,500 through market transactions on the Tokyo Stock Exchange between October 1 and October 31, 2026.The purchases were conducted under a board resolution d...
Kusuri No Aoki Reports October Sales and 15 New Outlets
KUSURI NO AOKI HOLDINGS CO., LTD. operates drugstores, dispensing pharmacies and supermarkets, with a regional retail focus across Japan.For October 2026, covering September 21 to October 20, all-store sales were reported at 111.5%, while existing-st...
Kusuri No Aoki Discloses No Share Buybacks Yet Under Ongoing Authorization
Kusuri No Aoki Holdings Co., Ltd. reported the status of its ongoing share buyback program authorized by a December 25, 2025 board resolution, which permits the repurchase of up to 6 million shares, or 6.32% of outstanding stock, for a maximum of 24...
Kusuri no Aoki posts robust September sales and accelerates store expansion
Kusuri no Aoki Holdings reported strong September sales for the fiscal year ending May 2027, with all-store sales up 12.8% year on year and existing-store sales rising 2.4%, driven by higher customer traffic and increased average spending per custome...
Kusuri no Aoki posts robust Q1 earnings and keeps strong full-year forecast
Kusuri no Aoki Holdings reported strong first-quarter results for the three months to August 20, 2026, with net sales up 13.8% to ¥159.0 billion and operating profit rising 16.0% to ¥8.4 billion. Profit attributable to owners of the parent jumped 36....
Kusuri No Aoki Reports No Activity in Ongoing Share Buyback Program
Kusuri No Aoki Holdings Co., Ltd. is a Japanese drugstore and retail pharmacy operator, selling pharmaceuticals and daily consumer goods through a chain-store model. The company is listed on the Tokyo Stock Exchange Standard and Nagoya Stock Exchange...
Kusuri no Aoki Posts Strong August Sales and Expands Store Network Nationwide
Kusuri no Aoki Holdings reported solid performance for August 2026, with all-store sales rising 10.7% year on year and existing-store sales up 0.7%, driven by higher customer traffic and steady gains in average spending per customer. The figures, bas...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 03, 2026
